Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

September Biotech Calendar
TheStreet.com
Tuesday, August 26, 2014 - 10:08am
tags:
Keryx, Orexigen, AstraZeneca, Nektar, Salix, Alimera, Amarin, Merck, EXACT Sciences, NPS Pharmaceuticals
3 Reasons Amgen Inc.'s Stock Could Fall
Motley Fool
Tuesday, August 26, 2014 - 10:00am
tags:
Amgen, Kyprolis
Merck’s Melanoma Drug To Get FDA Approval Earlier Than Expected
Bidness Etc.
Tuesday, August 26, 2014 - 9:47am
tags:
Merck, melanoma, FDA
Sekunjalo, U.S. Co. Partner on Cancer Vaccines: Business Report
Bloomberg
Tuesday, August 26, 2014 - 9:40am
tags:
Sekunjalo, vaccines, cancer, South Africa
New type 2 diabetes treatment Jardiance (empagliflozin) tablets for adults now available in U.S. pharmacies
Yahoo
Tuesday, August 26, 2014 - 9:35am
tags:
Jardiance, diabetes, Boehringer Ingelheim, Eli Lilly
Kite Pharma soars on added evidence that CAR-T treatment quells cancer
Fierce Biotech
Tuesday, August 26, 2014 - 8:32am
tags:
CAR-T, Kite Pharma, KTE-C19, B cell malignancies
Medtronic buys brain stimulation company for $200M
Yahoo/AP
Tuesday, August 26, 2014 - 8:28am
tags:
devices, Medtronic, M&A, Sapiens Steering Brain Stimulation
Pfizer/AstraZeneca: Ready for round 2?
CNBC
Tuesday, August 26, 2014 - 8:24am
tags:
M&A, Pfizer, AstraZeneca
Pfizer And Merck To Collaborate On Study Evaluating Novel Anti-Cancer Combination Regimen
Yahoo
Tuesday, August 26, 2014 - 8:23am
tags:
Pfizer, Merck, crizotinib, Pembrolizumab, non-small cell lung cancer, Xalkori
Jumping into global M&A mix key to India growing its pharma industry
Fierce Pharma
Monday, August 25, 2014 - 10:29pm
tags:
India, M&A, Lupin, Ranbaxy, Sun Pharma
Allergan v. Valeant: Here Comes the Lawsuit
Barron's
Monday, August 25, 2014 - 10:22pm
tags:
Allergan, Valeant Pharmaceuticals, M&A
Biotech Company Calithera Wakes Up Sleepy IPO Market
Silicon Beat
Monday, August 25, 2014 - 10:21pm
tags:
IPOs, Calithera, cancer
The 4 Companies Teaming Up For A New Tool To Fight Cancer
Yahoo/Benzinga
Monday, August 25, 2014 - 10:17pm
tags:
cancer, JNJ, Illumina, AstraZeneca, Sanofi, MiSeqDx, DNA sequencing
FDA grants orphan drug designation to potential Insys brain cancer treatment
Yahoo/AP
Monday, August 25, 2014 - 12:00pm
tags:
Insys, orphan drugs, FDA, CBD, glioblastoma multiforme
There's still hunger for 'blockbuster' biotech deals
CNBC
Monday, August 25, 2014 - 11:58am
tags:
biotech, Roche, InterMune, M&A
Former FDA head says biotech business model 'is basically falling apart'
Bizjournals.com
Monday, August 25, 2014 - 10:25am
tags:
FDA, biotech
J&J Paid Over $150K to Doctor Who Sat on FDA Safety Panels
New Brunswick Today, NJ
Monday, August 25, 2014 - 10:24am
tags:
JNJ, FDA, physician payments
Roche And InterMune Beckon Pharma's Summer of Discontent
Forbes
Monday, August 25, 2014 - 9:59am
tags:
Roche, InterMune, M&A
Galena Fires CEO Ahn, Offers No Parting Gifts
TheStreet.com
Monday, August 25, 2014 - 9:57am
tags:
Galena Biopharma, firings, Pharma CEOs, Mark Ahn
Kindred Biosciences Falls on Disappointing CereKin Data
Yahoo/Zacks.com
Monday, August 25, 2014 - 9:56am
tags:
Kindred Biosciences, CereKin, animal health, osteoarthritis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.